Galanthamine total synthesis

Galanthamine total synthesis concerns the total synthesis of galanthamine, a drug used for the treatment of mild to moderate Alzheimer’s disease.^[1]

The natural source of galantamine are certain species of daffodil and because these species are scarce and because the isolation of galanthamine from daffodil is expensive (a 1996 figure specifies 50,000 US dollar per kilogram, the yield from daffodil is 0.1-0.2% dry weight) alternative synthetic sources are under development by means of total synthesis. One recent publication details the enantioselective organic synthesis of galanthamine and also that of morphine from a single precursor.

Additional recommended knowledge

Correct Test Weight Handling Guide: 12 Practical Tips

Better weighing performance in 6 easy steps

Recognize and detect the effects of electrostatic charges on your balance

1 Synthetic galanthamine timeline
2 Sanochemia industrial production
3 Trost Galanthamine synthesis
4 Eli Lilly / U. of Southampton Galanthamine synthesis
5 References

Synthetic galanthamine timeline

1962: Preparation of racemic galanthamine and epi-galanthamine by organic reduction of racemic narwedine by D. H. R. Barton. Narwedine is the related enone (galanthamine the allyl alcohol) obtained in an oxidative coupling. Chemical yield: 1.4%. In addition they isolated (-)-narwardine by chiral resolution from a mixture of racemix narwedine and 0.5 equivalents of (+)-galanthamine. In this way they were able to obtain (-)galanthamine again by reduction
1976: Kametani obtains both galanthamine enantiomers by using a derivative of tartaric acid as a chiral resolving agent.
1977: Koga obtains both enantiomers via a chiral pool synthesis starting from L-tyrosine.
1988: Carrol optimizes the oxidative coupling route to 11% yield based on isovanillin
1989: Vlahov exploits asymmetric reduction by biocatalysis in the synthesis of several galanthamine precursors.
1994: Shieh/Carlson ^[2] obtain (-)-galanthamine by spontaneous resolution of its narwedine precursor. Racemic narwedine is treated with 0.01 equivalent of (+)-galanthamine resulting in a 76% yield. Narwedine is a racemic conclomerate allowing the isolation of the S,S enantiomer from the R,R enantiomer by simple crystallization. What makes the process unique is that both enantiomers are in dynamic chemical equilibrium with each other though a common phenol in a Michael reaction-like reaction brought about by triethylamine:

1999: Jordis performs (-)-galanthamine synthesis on a multikilogram scale based on Carrol chemistry and Shieh/Carlson chiral resolution. This would become the basis for current industrial production by Sanochemia (USA).
2000:Felse proposes an intramolecular Heck reaction for the construction of the galanthamine backbone.
2000: Trost/Toste obtain (-)-galanthamine in an asymmetric synthesis involving asymmetric allylic alkylation and an intramolecular Heck reaction. Improved methods were published in 2002 and 2005 (see below)
2004: Node obtains (-)-galanthamine via a remote asymmetric induction method with starting chiral compound D-phenylalanine

Sanochemia industrial production

The method outlined by Jordis in 1999 forms the basis for industrial galanthamine production.^[3]


Narwedine synthesis part A		Narwedine synthesis part B

This method starts by Electrophilic halogenation of 3,4-dimethoxybenzaldehyde 1 (accessible from isovanillin) with bromine / acetic acid to organobromide 2 followed by regioselective demethoxylation with sulfuric acid to phenol 3. This compound reacts in a reductive amination (sodium borohydride) with tyramine 4 to amine 5 which is formylated with ethyl formate and formic acid in dioxane in the next step to compound 6. An oxidative phenol coupling takes place next with Potassium ferricyanide and potassium carbonate in toluene to 7. The C8a-C14 bond is formed in the first step followed by a Michael addition of the other phenolic group to the newly formed enone group. The reaction step creates two stereocenters leading to two diastereomeric pairs of enantiomers. By the nature of the ABD skeleton the desired S,S/R,R pair is the major product formed and the other pair S,R/R,S is removed in workup. The ketone group is protected as the ketal 8 with 1,2-propylene glycol enabling the organic reduction by lithiumaluminiumhydride of both the bromine group and the formyl group. In the second phase the ketal group is removed (hydrochloric acid) forming racemic (S,S/R,R) narwedine 9.

Enantiopure (-)-narwedine is obtained via the dynamic chiral resolution method pioneered by Shieh/Carlson and in the final step the ketone is reduced to the alcohol with L-selectride.

This final step is enantioselective producing the desired S,S,R compound because approach of H^- is restricted to the Si face as the Re face is shielded by the DB ring system. Formation of the S,S,S epimer is also avoided by keeping reaction temperature below -15°C.

Trost Galanthamine synthesis

The total synthesis of galanthamine (Trost 2005) ^[4] is described as follows (see scheme 1): the sequence starts by bromination by electrophilic aromatic substitution of isovanillin 1 to bromophenol 2, then by synthesis of the second intermediate 5 by reacting dialdehyde 3 in a coupled aldol reaction and Horner-Wadsworth-Emmons reaction with trimethyl phosphonoacetate 4. The hydroxyl group is activated as a leaving group by acetylation with trichloroethyl carbonate (Troc) to 6. Next an enantioselective Trost AAA reaction takes place between bromophenol 2 and carbonate 6 to the allyl ether 7. Next the aldehyde group is protected as an acetal in 8 and this step enables the to organic reduction of the ester group to the alcohol 9 with DIBAH and subsequent conversion of this alcohol to a nitrile by nucleophilic displacement to 10 followed by aldehyde deprotection to 11. The intramolecular Heck reaction to 12 creates the dihydrofuran ring. Allylic oxidation by selenium dioxide provides allylic alcohol 13 with the correct stereochemistry. The aldehyde reacts with methylamine to the imine 14 and reduction of the imine and nitrile by DIBAL-H leading to ring-closure to the hemi-aminal 15 (not isolated) followed by acid quenching gives the alcohol 16. In the final step this alcohol group is reduced to give Galanthamine 17 together with 6% of the epi isomer 18.^[5]

Eli Lilly / U. of Southampton Galanthamine synthesis

A total synthesis reported by Eli Lilly and the University of Southampton in 2007 also starts from isovanillin.^[6] The aldehyde group in its derivative 1 is converted to its amine by reductive amination with methylamine which is then protected as a BOC group in 2. The remainder of the carbon framework is added with chiral propargyl alcohol 3 (introducing the 4a stereocenter and obtained by chiral synthesis of the ketone with R-Alpine borane) in a Mitsunobu reaction to aryl ether 4. The trimethylsilyl protective group is removed by potassium carbonate in methanol and the subsequent enyne metathesis reaction with Grubbs' catalyst gives diene 5. A Hydroboration-oxidation reaction converts 5 to alcohol 6 and an intramolecular heck reaction affords tricycle 7 with alkene isomerization and establishment of the 8a stereocenter with correct stereochemistry based on chiral induction. The allyl alcohol group in 8 is introduced by selenoxide oxidation with an excess of the desired diastereomer. In the final step to galanthamine 9 the hydroxyl group is activated as the triflate and the amine group as the mesylate for intramolecular azepine ring closure via nucleophilic substitution (with 6% epimer formation).


Galanthamine synthesis 2007 A		Galanthamine synthesis 2007 part B

References

^ Synthesis and Pharmacology of Galantamine José Marco-Contelles, Maria do Carmo Carreiras, Carolina Rodríguez, Mercedes Villarroya, and Antonio G. García Chem. Rev.; 2006; 106(1) pp 116 - 133; (Review) doi:10.1021/cr040415t
^ Asymmetric Transformation of Either Enantiomer of Narwedine via Total Spontaneous Resolution Process, a Concise Solution to the Synthesis of (-)-Galanthamine Wen-Chung Shieh and John A. Carlson J. Org. Chem.; 1994; 59(18) pp 5463 - 5465; doi:10.1021/jo00097a060
^ Development of a Pilot Scale Process for the Anti-Alzheimer Drug (-)-Galanthamine Using Large-Scale Phenolic Oxidative Coupling and Crystallisation-Induced Chiral Conversion Bernhard Küenburg, Laszlo Czollner, Johannes Fröhlich, and Ulrich Jordis Org. Process Res. Dev.; 1999; 3(6) pp 425 - 431; (Article) doi:10.1021/op990019q
^ Divergent Enantioselective Synthesis of (-)-Galanthamine and (-)-Morphine Barry M. Trost, Weiping Tang, and F. Dean Toste J. Am. Chem. Soc.; 2005; 127(42) pp 14785 - 14803; (Article) DOI: 10.1021/ja054449+ Abstract
^ a bromine, sodium acetate, acetic acid, iron, rt b potassium carbonate, 2days c Troc-Cl, DMAP, Pyridine, dichloromethane d palladium,Trost ligand, triethylamine, dichloromethane e 1.5 mol % TsOH, CH(OMe)₃, methanol f DIBAL-H, toluene, -78 °C, 1 hr g triphenylphosphine, acetonecyanohydrin, DIAD, diethyl ether h 2.20 mol % TsOH, THF, water i 15 mol % Palladium(II) acetate, 15 mol% dppp, 3 eq. Ag₂CO₃, toluene, 107 °C j selenium dioxide disodium hydrogen phosphate dioxane, 150 °C 3 hrs k methylamine ,methanol l 4 eq. DIBAL-H, m aqueous NaH₂PO₄ n NaCNBH₃
^ Stereocontrolled Synthesis of (-)-Galanthamine Vachiraporn Satcharoen, Neville J. McLean, Stephen C. Kemp, Nicholas P. Camp, and Richard C. D. Brown Org. Lett.; 2007; 9(10) pp 1867 - 1869; (Letter) doi:10.1021/ol070255i